Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
7.
Med. clín (Ed. impr.) ; 133(18): 689-693, nov. 2009. tab, graf
Article in Spanish | IBECS | ID: ibc-83824

ABSTRACT

Fundamento y objetivo: El cáncer de esófago (CE) es una enfermedad poco frecuente pero grave. El objetivo del presente trabajo es describir las características clinicopatológicas y la supervivencia de los pacientes con CE en nuestro hospital. Pacientes y método: Se estudió a 200 pacientes consecutivos diagnosticados o tratados de CE o de la unión gastroesofágica en el Hospital Donostia entre enero del año 2003 y diciembre del año 2007. Se analizó la localización del tumor, el tipo histológico, las pruebas realizadas para establecer el estadio tumoral, los tratamientos utilizados, la supervivencia y la morbimortalidad de la cirugía. Resultados: La ultrasonografía endoscópica (USE) modificó la estrategia terapéutica en un 12% de los pacientes. Un 32% (74) de los pacientes se operaron; de éstos, un 65% (48) recibió radioquimioterapia (RT-QM) neoadyuvante. La supervivencia al año, a los 3 años y a los 5 años fue del 48, el 25 y el 21%, respectivamente. La mortalidad postoperatoria fue del 8% (6 pacientes) y la morbilidad, del 57% (42 pacientes). Los pacientes en estadio III a los que se realizó RT-QM neoadyuvante y cirugía tuvieron un mejor pronóstico que aquéllos a los que sólo se hizo RT-QM (20 meses de supervivencia frente a 9 meses). En el análisis multivariante, los factores de mal pronóstico fueron la localización en el tercio medio (HR [hazard ratio ‘razón de riesgo’]=2,3; intervalo de confianza [IC] del 95%: 1,3–4,1) y la no realización de cirugía tras la RT-QM (HR=1,9; IC del 95%: 1,15–3) (AU)


Background and objective: The esophageal cancer (EC) is a slightly frequent but serious disease. Our aim is to describe the characteristics of the patients with EC in our Hospital. Patients and method: We included 200 patients consecutively diagnosed and/or treated for CE between between January, 2003 and December, 2007. The location of the tumor was analyzed, the histological type, the proofs realized for to establish the classification, the treatments, the survival and the morbi-mortality of the surgery. Results: The endoscopic ultrasonography (EUS) modified the therapeutic strategy in 12% of the patients. The survival to the year, 3 years and 5 years was 48%, 25% and 21%, respectively. 74 (32%) patients were operated, 48 (65%) of them was treated with neoadyuvant chemoradiotherapy. The postsurgical mortality was 8% (6 patients) and the morbidity was 57% (114 patients). In multivariate analysis, after adjustment for traditional risk factors, were the location in the average third ( [HR, hazard ratio]=2.3; confidence interval [IC] of 95%, 1.3–4.1) and not accomplishment of surgery after the chemotherapy and radiotherapy (HR=1.9; IC to 95%, 1.15–3). Conclusions: The diagnosis is realized very later. The EUS has contributed a better therapeutic strategy to our patients. The mortality continues being high (AU)


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Esophageal Neoplasms/mortality , Survival Rate , Esophageal Neoplasms/physiopathology , Esophageal Neoplasms/diagnosis , Indicators of Morbidity and Mortality , Multivariate Analysis , Prognosis
8.
Med Clin (Barc) ; 133(18): 689-93, 2009 Nov 14.
Article in Spanish | MEDLINE | ID: mdl-19767034

ABSTRACT

BACKGROUND AND OBJECTIVE: The esophageal cancer (EC) is a slightly frequent but serious disease. Our aim is to describe the characteristics of the patients with EC in our Hospital. PATIENTS AND METHOD: We included 200 patients consecutively diagnosed and/or treated for CE between between January, 2003 and December, 2007. The location of the tumor was analyzed, the histological type, the proofs realized for to establish the classification, the treatments, the survival and the morbi-mortality of the surgery. RESULTS: The endoscopic ultrasonography (EUS) modified the therapeutic strategy in 12% of the patients. The survival to the year, 3 years and 5 years was 48%, 25% and 21%, respectively. 74 (32%) patients were operated, 48 (65%) of them was treated with neoadjuvant chemoradiotherapy. The postsurgical mortality was 8% (6 patients) and the morbidity was 57% (114 patients). In multivariate analysis, after adjustment for traditional risk factors, were the location in the average third ( [HR, hazard ratio]=2.3; confidence interval [IC] of 95%, 1.3-4.1) and not accomplishment of surgery after the chemotherapy and radiotherapy (HR=1.9; IC to 95%, 1.15-3). CONCLUSIONS: The diagnosis is realized very later. The EUS has contributed a better therapeutic strategy to our patients. The mortality continues being high.


Subject(s)
Esophageal Neoplasms/mortality , Esophageal Neoplasms/pathology , Aged , Female , Humans , Male , Middle Aged , Prognosis , Survival Rate
9.
Cir. Esp. (Ed. impr.) ; 85(5): 280-286, mayo 2009. ilus, tab
Article in Spanish | IBECS | ID: ibc-59627

ABSTRACT

Objetivo: Describir los datos enviados al Registro Nacional de Cirugía Gástrica por laparoscopia y analizar el tipo de cirugía, la reconversión, las complicaciones postoperatorias y la mortalidad. Pacientes y método: Desde marzo de 2005 a julio de 2008 han sido remitidos al registro 302 pacientes a través de un cuestionario ubicado en la página web de la Asociación Española de Cirujanos, donde se registraron datos clinicopatológicos, características de la cirugía realizada, reconversión y morbimortalidad. Resultados: Se ha intervenido a 245 pacientes por adenocarcinoma gástrico, 35 por tumores estromales y 22 por otras afecciones. En los adenocarcinomas gástricos se realizó cirugía resectiva en 232 (95%) casos. La localización predominante fue el tercio distal y el tipo de tumor más frecuente, el intestinal. El 34% fueron tumores localmente avanzados. Se realizó una linfadenectomía D2 en 117 casos, D1 en 105 y D0 en 6. Se realizó reconversión en 21 (9%), y entre las causas destacan las dificultades técnicas. Se han descrito complicaciones postoperatorias en 72 (31%) casos, entre las que destacan por su gravedad las fístulas digestivas. Hubo una mortalidad postoperatoria del 6%, y las causas más frecuentes fueron la sepsis por fuga anastomótica y las complicaciones cardiorrespiratorias. La estancia media hospitalaria en los pacientes que no presentaron complicaciones fue de 9,2±3 días. Conclusiones: La gastrectomía laparoscópica en el cáncer gástrico es un procedimiento factible que no está exento de dificultades técnicas. Una considerable tasa de complicaciones postoperatorias pueden llegar a condicionar los beneficios de la cirugía mínimamente invasiva(AU)


Objective: To study the data from the Laparoscopic Gastric Surgery Spanish National Register of laparoscopic Gastric Surgery and to analyse the type of surgery, the conversion to laparotomy, postoperative complications and mortality. Patients and Method: From March 2005 to July 2008, details of 302 laparoscopic gastric surgical interventions were sent to the Association of Spanish Surgeons web-site. Details of surgical technique, reconversion, clinical and pathological data, morbidity and mortality were collected and analysed. Results: A total of 245 patients had gastric adenocarcinoma, 35 of them stromal tumours and 22 other gastric pathologies. In gastric adenocarcinoma patients, resection was performed in 232 cases (95%). The most frequent histology was intestinal, mainly located in the distal third of the stomach, with 34% of the tumours being locally advanced. D2 lymphadenectomy was performed in 117 cases, D1 in 105, and D0 in 6. Reconversion was needed in 21 cases (9%), with technical difficulty being the most frequent cause . Postoperative complications were reported in 72 patients (31%), with anastomotic leak being one of the most significant. Postoperative mortality was 6%, with sepsis due to anastomotic leak and cardiac or respiratory complications the most frequent causes. The mean hospital stay of patients without complications was 9.2±3 days.Conclusions: Laparoscopic gastrectomy for gastric cancer is a feasible but technically demanding procedure. Potential benefits of minimal invasive surgery can be reduced due to a high rate of postoperative complications(AU)


Subject(s)
Humans , Male , Female , Middle Aged , Laparoscopy/statistics & numerical data , Stomach Neoplasms/epidemiology , Forms and Records Control/statistics & numerical data , Postoperative Complications/epidemiology , Postoperative Complications/mortality , Surveys and Questionnaires , Indicators of Morbidity and Mortality , Lymph Node Excision/statistics & numerical data , Gastrectomy/statistics & numerical data , Digestive System Surgical Procedures/statistics & numerical data , Stomach Neoplasms/surgery , Forms and Records Control/classification , Medical Records/statistics & numerical data , Stomach Neoplasms/complications , Surveys and Questionnaires/classification , Adenocarcinoma/complications , Adenocarcinoma/epidemiology , Gastrointestinal Stromal Tumors/epidemiology
10.
Cir Esp ; 85(5): 280-6, 2009 May.
Article in Spanish | MEDLINE | ID: mdl-19371864

ABSTRACT

OBJECTIVE: To study the data from the Laparoscopic Gastric Surgery Spanish National Register of laparoscopic Gastric Surgery and to analyse the type of surgery, the conversion to laparotomy, postoperative complications and mortality. PATIENTS AND METHOD: From March 2005 to July 2008, details of 302 laparoscopic gastric surgical interventions were sent to the Association of Spanish Surgeons web-site. Details of surgical technique, reconversion, clinical and pathological data, morbidity and mortality were collected and analysed. RESULTS: A total of 245 patients had gastric adenocarcinoma, 35 of them stromal tumours and 22 other gastric pathologies. In gastric adenocarcinoma patients, resection was performed in 232 cases (95%). The most frequent histology was intestinal, mainly located in the distal third of the stomach, with 34% of the tumours being locally advanced. D2 lymphadenectomy was performed in 117 cases, D1 in 105, and D0 in 6. Reconversion was needed in 21 cases (9%), with technical difficulty being the most frequent cause. Postoperative complications were reported in 72 patients (31%), with anastomotic leak being one of the most significant. Postoperative mortality was 6%, with sepsis due to anastomotic leak and cardiac or respiratory complications the most frequent causes. The mean hospital stay of patients without complications was 9.2 +/- 3 days. CONCLUSIONS: Laparoscopic gastrectomy for gastric cancer is a feasible but technically demanding procedure. Potential benefits of minimal invasive surgery can be reduced due to a high rate of postoperative complications.


Subject(s)
Laparoscopy , Stomach Neoplasms/surgery , Aged , Female , Humans , Laparoscopy/adverse effects , Male , Postoperative Complications/epidemiology , Registries
SELECTION OF CITATIONS
SEARCH DETAIL
...